A Randomized, Real-world Head-to-head Study of Dupilumab Versus Mepolizumab in Danish CRSwNP Patients
Conditions: Chronic Rhinosinusitis With Nasal Polyps; Asthma; Eosinophilic; Eosinophilia Interventions: Biological: dupilumab; Biological: mepolizumab Sponsor: Rigshospitalet, Denmark Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials